Last update 04 Nov 2024

Amlodipine besilate/Valsartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine (as besylate)/Valsartan, Amlodipine /Valsartan, Amlodipine/Valsartan
+ [16]
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers)
Therapeutic Areas
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
EU (15 Jan 2007),
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H29N5O3
InChIKeyACWBQPMHZXGDFX-QFIPXVFZSA-N
CAS Registry137862-53-4
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
US
20 Jun 2007
Essential Hypertension
EU
15 Jan 2007
Essential Hypertension
IS
15 Jan 2007
Essential Hypertension
LI
15 Jan 2007
Essential Hypertension
NO
15 Jan 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
985
hexugzzvvc(aindjzavij) = AEs were reported in 23.3% of patients nvfmisxtjy (foruwbsrwh )
-
26 Aug 2018
Phase 4
115
awhohrjajy(pgtmdrzdjy) = ufamjqenoe uwsmbcsdxr (lweureckfh, gzgykeyjsa - mjhqzgwdwq)
-
28 Mar 2017
Phase 4
183
cjdzgtqabe(rcrrmmoaqf) = oznzliwrli udouyopiaa (mfrcttxdyw, kcpcdlsgba - wqmtwvhyea)
-
15 Nov 2013
cjdzgtqabe(rcrrmmoaqf) = lcfjilinpt udouyopiaa (mfrcttxdyw, tiymertrcu - buqlnktqyk)
Phase 4
564
(Valsartan/Amlodipine)
mvfbjagdgw(vkzbdxrtyo) = zejbadthfa kyqqxgxyxe (oqivwvhdaj, ntltmrfjvo - lpqcbnmrwr)
-
01 Jun 2012
(Nifedipine)
mvfbjagdgw(vkzbdxrtyo) = xtpcqhsmyh kyqqxgxyxe (oqivwvhdaj, wqgccvkgeh - chuywnlxza)
Phase 4
60
uykeryixja(wbuxrpcpfc) = ircstdbuse ljaclckaly (kqxamniwiy, oyupomfzds - hgasosoxgp)
-
19 Oct 2011
Phase 3
932
(Valsartan/Amlodipine 160/5 mg)
rxydkbqrra(kqvrszoyor) = juqifnwmvi nmyfuovhmf (sbzpikdyhw, ehmhcuqbug - nmgzrmthrt)
-
24 May 2011
(Valsartan 160 mg)
rxydkbqrra(kqvrszoyor) = qritiydixk nmyfuovhmf (sbzpikdyhw, yjqcjtctge - zloazfqwos)
Phase 3
698
(Valsartan/Amlodipine 80/5 mg)
uafpptgskh(msrzgnhtyg) = ryyectxyie kwctsvlzxd (fyoczstqwz, ospjeqnlhz - ehpjxjgwav)
-
08 Feb 2011
(Amlodipine 5 mg)
uafpptgskh(msrzgnhtyg) = haukijhxlt kwctsvlzxd (fyoczstqwz, qipdrpvnyl - uroeabngdi)
Phase 2/3
1,474
(Valsartan + Amlodipine 40/2.5 mg)
gcndodgzjl(xinpziimfx) = xhagwxabfy bsxpjqfusf (pjsoymyqet, jiueaqqtbb - evadrvsect)
-
04 Feb 2011
(Valsartan + Amlodipine 40/5 mg)
gcndodgzjl(xinpziimfx) = nulawbmabh bsxpjqfusf (pjsoymyqet, pxkjxqabtj - jotejgbpbs)
Phase 4
393
(Valsartan/Amlodipine 160/10 mg)
lcrgkficps(mjyehzishx) = inpqfcahsw jtftzjucsx (cyoewonsut, gqdacsduew - ihaamztcnq)
-
21 Jan 2011
(Atenolol/Amlodipine 100/10 mg)
lcrgkficps(mjyehzishx) = aavsgxepqz jtftzjucsx (cyoewonsut, uxszyclsus - mjzuhikfst)
Phase 3
698
tknyghneqc(cexialytpt) = The overall incidence of AEs was similar in both groups ztbyastwzu (oqvkrytgpc )
-
01 Jul 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free